Comparison of linear versus macrocyclic gadolinium chelates in rat skeletal muscle
View/ Open
Access
info:eu-repo/semantics/openAccessDate
2022Author
Balık, Mehmet SabriÇeliker, Fatma Beyazal
Tümkaya, Levent
Mercantepe, Tolga
Topçu, Atilla
Şahin, Rıfat
Balık, Gülşah
Metadata
Show full item recordCitation
Balik, M. S., Celiker, F. B., Tumkaya, L., Mercantepe, T., Topcu, A., Sahin, R., & Balik, G. (2022). Comparison of linear versus macrocyclic gadolinium chelates in rat skeletal muscle. Northern clinics of Istanbul, 9(6), 632–637. https://doi.org/10.14744/nci.2021.45143Abstract
OBJECTIVE: We investigated the effects on skeletal muscle of gadolinium based linear and macrocyclic radiocontrast agents
applied at experimental intervals using histopathological methods.
METHODS: Thirty-two male Sprague–Dawley rats were included in the study for histopathological analysis. No procedure
was performed on the healthy control group. The sham group received 0.1 ml/kg intravenous (IV) saline solution through
the tail vein 4 times weekly for 5 weeks. The gadodiamide group received total 2 mmol/kg IV gadodiamide through the tail
vein 4 times weekly for 5 weeks. The gadoteric-acid group received 2 mmol/kg IV gadoteric acid through the tail vein 4 times
weekly for 5 weeks.
RESULTS: We determined no marked apoptotic myofibrils associated withcaspase-3 expression in these two groups. Furthermore, no calcineurin expression was observed in myofibrils in the two groups. However, quantitative analyses revealed
a decrease in muscle-fiber area in the gadodiamide and gadoteric-acid groups compared to the control group (Respectively;
p=0.001 and p=0.017).
CONCLUSION: In our experimental study, linear and macrocyclic GBCAs applied at repeated doses played no role in myofibril damage induced by caspase-3 and calcineurin – nuclear factor of activated T-cells in skeletal muscle tissue.